Dutch biotech Avidicure has launched with $50 million in seed financing to support development of a novel class of ...

US biopharma Novavax (Nasdaq: NVAX) closed 20% higher on Wednesday after announcing an update on its COVID-19 vaccine. The US ...

Denmark’s Zealand Pharma (CPH: ZEAL), a company focused on the discovery and development of innovative peptide-based ...

South Korea’s Samsung Bioepis today released its Second Quarter 2025 Biosimilar Market Report, which provides the second ...

Zurich-based biotech MetrioPharm has appointed Stephan Rietiker as chair of its board of directors, following a unanimous ...

US biotech Grove Biopharma has secured $30 million in a series A round to move its lead program targeting advanced prostate ...

French pharma major Sanofi delivered a set of first-quarter financial results that seemed to satisfy markets Thursday, as its ...

Swiss pharma giant Roche (ROG: SIX) today reported that it achieved sales growth of 6% (7% in francs) to 15.4 billion francs ...

Bristol Myers Squibb (NYSE: BMY) beat Wall Street expectations in the first quarter of 2025, sending shares higher in early ...

Drug distributors like Cardinal Health, Cencora and McKesson will play a key role in the drug supply chain, improving patient ...

UK-based pharma company Indivior (LSE: INDV) saw it shares rose 5.3% to 738.50 pence in early trading today after it ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Skyclarys (omaveloxolone), the first treatment ...